CEVI.ST · PEAD ↓ 80
CellaVision reported Q1 2026 EPS of 0.94 on 2026-04-24, missing the 1.62 consensus by 0.68 (-42.0%); no prior-year comparable is available in the current data feed.
CellaVision reported Q1 2026 EPS of 0.94 on 2026-04-24, missing the 1.62 consensus by 0.68 (-42.0%); no prior-year comparable is available in the current data feed.
Print-day reaction was -21.5% versus the prior close, a sharp gap-down open that carried through the session as the market repriced the EPS miss. The overnight gap to the T+1 open recovered a modest +1.7%, suggesting no sustained aftermarket selling pressure. Over days 1–3, price drifted a further +0.8% on a close-to-close basis, a marginal continuation that did not materially offset the initial collapse. Cumulative abnormal return of -20.4% versus SPY.US firmly anchors this in PEAD short territory; the documented drift pattern holds through the holding window ending 2026-07-22.